Chelsea Counsel Company’s Gilead Sciences GILD Stock Holding History

Chelsea Counsel Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$558	Hold	4	–	–	﹤0.01%	224
2025 Q4	$491	Hold	4	–	–	﹤0.01%	231
2025 Q3	$444	Buy	+4	New	+$455	﹤0.01%	235
2017 Q1	–	Sell	-3,994	Closed	-$286K	–	84
2016 Q4	$286K	Sell	3,994 -254	-6%	-$18.9K	0.15%	78
2016 Q3	$336K	Sell	4,248 -146	-3%	-$11.9K	0.17%	74
2016 Q2	$367K	Hold	4,394	–	–	0.17%	77
2016 Q1	$404K	Hold	4,394	–	–	0.13%	86
2015 Q4	$445K	Sell	4,394 -4,400	-50%	-$458K	0.13%	82
2015 Q3	$863K	Buy	8,794 +2,600	+42%	+$289K	0.21%	62
2015 Q2	$725K	Buy	6,194 +300	+5%	+$32.8K	0.16%	69
2015 Q1	$578K	Buy	5,894 +500	+9%	+$50.8K	0.12%	75
2014 Q4	$508K	Sell	5,394 -200	-4%	-$20.7K	0.1%	82
2014 Q3	$595K	Buy	5,594 +1,500	+37%	+$147K	0.12%	76
2014 Q2	$339K	Sell	4,094 -200	-5%	-$15.6K	0.07%	99
2014 Q1	$304K	Sell	4,294 -1,000	-19%	-$78.4K	0.06%	102
2013 Q4	$398K	Buy	+5,294	New	+$369K	0.09%	74

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Chelsea Counsel Company's GILD Position: Q1 2026 in Review

Chelsea Counsel Company held its Gilead Sciences (GILD) position steady in Q1 2026 at 4 shares worth $558. The position accounts for ﹤0.01% of the portfolio, ranked #224.

Chelsea Counsel Company first reported a position in GILD in Q4 2013 and has held it in 16 quarters since. The position peaked at $863K in Q3 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Chelsea Counsel Company held 4 shares of Gilead Sciences worth $558 as of Q1 2026.
Chelsea Counsel Company left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up ﹤0.01% of Chelsea Counsel Company's portfolio in Q1 2026, its #224 holding.
Chelsea Counsel Company first reported a position in Gilead Sciences in Q4 2013 and has held it in 16 quarters since.
Chelsea Counsel Company's Gilead Sciences position peaked at $863K in Q3 2015.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.